SEC Form 4 · accession 0001104659-17-018473
Esperion Therapeutics, Inc. · ESPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gilbert S Omenn
Director
Period of report
Mar 21, 2017
Accepted (ET)
Mar 22, 2017 · 8:02 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 21, 2017 | P | 1,000 | $42.26 | A | 1,000 | I | By Gilbert S. Omenn Revocable Trust |
| Common Stock | holding | — | — | — | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.